Intellia Therapeutics, Inc.

NTLA · NASDAQ
Analyze with AI
$9.11+$0.085 (+0.94%)
At close:Dec 15, 2025, 7:29 PM UTC
$9.11+$0.00 (+0%)
After hours:Dec 15, 2025, 7:29 PM UTC
P/E TTM-2.25
P/B TTM1.34
P/S TTM16.58
Dividend Yield0%
EPS-$4.25
Beta2.135
Valuation
PEG Ratio-0.25
FCF Yield-43.25%
EV / EBITDA-2.39
Quality
ROIC-42.76%
Gross Margin67.05%
Cash Conv. Ratio0.92
Growth
Revenue 3Y CAGR3.55%
FCF Growth13.09%
Safety
Net Debt / EBITDA0.27
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle-1,816.06

Intellia Therapeutics, Inc. (NTLA) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Intellia Therapeutics, Inc. (NTLA) stock price today?

As of Dec 15, 2025, 7:29 PM UTC, Intellia Therapeutics, Inc. (NTLA) stock is trading at $9.11. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NTLA stock quotes for informed trading decisions.

What is Intellia Therapeutics, Inc.'s market capitalization?

Intellia Therapeutics, Inc. (NTLA) has a market capitalization of approximately $954.1M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Intellia Therapeutics, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the NTLA stock price changes.

What is the 52-week range for Intellia Therapeutics, Inc. stock?

Intellia Therapeutics, Inc. (NTLA) stock has traded in a 52-week range of $5.90 — $28.25. The 52-week range shows the highest and lowest prices at which NTLA traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Intellia Therapeutics, Inc. stock price to this range provides context for recent price action.

How much trading volume does Intellia Therapeutics, Inc. stock have?

Intellia Therapeutics, Inc. (NTLA) stock recently traded approximately 2.4M shares. Trading volume indicates market liquidity and investor interest in NTLA. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Intellia Therapeutics, Inc. stock.

Does Intellia Therapeutics, Inc. pay dividends to shareholders?

Yes, Intellia Therapeutics, Inc. (NTLA) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Intellia Therapeutics, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Intellia Therapeutics, Inc.'s intraday price range?

Today, Intellia Therapeutics, Inc. (NTLA) stock has traded in a range of $8.90 — $9.23. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NTLA's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Intellia Therapeutics, Inc. stock data?

AlphaPilot sources real-time NTLA stock quotes, fundamental financial data, and historical price charts for Intellia Therapeutics, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Intellia Therapeutics, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NTLA stock performance.